NCT00035958View on ClinicalTrials.gov

Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis

PHASE2/PHASE3TerminatedINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions

Dermatomyositis

Interventions

DRUG

Prednisone

DRUG

Methotrexate

DRUG

Etanercept

Trial Locations (1)

45229

Cincinnati Childrens Hospital Medical Center, Cincinnati

Sponsors

Collaborators (1)

Immunex Corporation

All Listed Sponsors

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

collaborator

Immunex Corporation

INDUSTRY

lead

Children's Hospital Medical Center, Cincinnati

OTHER